Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis

    Science

 LAU-7b

Events

Laurent Pharmaceuticals to participate at RESI on MaRS, April 10th 2018, Toronto, Canada

Laurent Pharmaceuticals to participate at the Biotech Showcase, January 8-10th 2018, San Francisco, CA, USA

 

News

Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

Read more  

Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

Read more